NEW YORK (GenomeWeb News) — The US Senate yesterday confirmed Andrew von Eschenbach to be the new commissioner off the Food and Drug Administration.
The Bush appointee, a staunch supporter of genomic technologies in drug discovery, was approved after serving as acting commissioner since September 2005 after former commissioner Lester Crawford resigned.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.